| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 04/20/2011 | EP2310013A1 Bicyclic triazole derivatives for treating tumors |
| 04/20/2011 | EP2220070B1 2-benzylpyridazinone derivatives as met kinase inhibitors |
| 04/20/2011 | EP1517908B1 Novel benzimidazole derivatives |
| 04/20/2011 | EP1505963B1 Hepatitis c virus inhibitors |
| 04/20/2011 | CN1990470B Phthiobuzonum derivative, its manufacturing process, pharmaceutical combination and uses thereof |
| 04/20/2011 | CN102026996A Pyridazine derivatives as factor XIA inhibitors |
| 04/20/2011 | CN102026993A New compounds III |
| 04/20/2011 | CN102026992A Novel HSP inhibitory carbazole derivatives, compositions containing same, and use thereof |
| 04/20/2011 | CN102026980A Isoquinolinone derivatives as NK3 antagonists |
| 04/20/2011 | CN102026974A Tetrahydrocyclopenta[b]indole androgen receptor modulators |
| 04/20/2011 | CN102026972A New substituted spiro[cycloalkyl-1,3'-indol]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102024907A Photoelectric conversion device, production method thereof, photosensor, imaging device and their drive methods |
| 04/20/2011 | CN102020640A Tetrahydroindolone and tetrahydroindolone derivative as well as preparation method and medical application thereof |
| 04/20/2011 | CN101602703B Pyrrole group-containing compound and preparation method and application thereof |
| 04/20/2011 | CN101318954B Cyanuric chloride derivant, preparation method and application thereof |
| 04/20/2011 | CN101141956B Use of CRTH2 antagonist compounds in therapy,its preparation method and pharmaceutical uses |
| 04/19/2011 | US7928245 Alcohols containing imide moieties and reactive oligomers prepared therefrom |
| 04/19/2011 | US7928231 Thienopyrazoles |
| 04/19/2011 | US7928227 2-oxo-1,3,5-perhydrotriazapine derivatives useful in the treatment of hyper-proliferative, angiogenesis, and inflammatory disorders |
| 04/19/2011 | US7928137 Meta-benzamidine derivatives as serine protease inhibitors |
| 04/19/2011 | US7928133 Compounds and compositions as hedgehog signaling pathway modulators |
| 04/19/2011 | US7928131 Imidazole compounds |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928122 Modulators of cellular adhesion |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928109 focal adhesion kinase inhibitor, i.e. FAK inhibitor; tyrosine kinase inhibitors; cancer, osteoporosis; e.g. N-methyl-4-({4-[({3-[methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
| 04/19/2011 | US7928104 Enhances sensitivity to radiotherapy and chemotherapy; synergistic; hydrolysis of a 2-methoxyquinoline or 2-methoxyquinoxaline; cyclization of a N-phenyl phenylacrylamide; or condensation of an o-benzenediamine with a keto-ester; preferred oxalate salt; side effect reduction |
| 04/19/2011 | US7927830 Modified carbocyanine dyes and their conjugates |
| 04/19/2011 | US7927623 Pleasant taste; bioabsorbable; overcoated water insoluble drug in alcohol solvent and water soluble binder; mixing, compression |
| 04/19/2011 | CA2591257C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 04/19/2011 | CA2553704C Substituted benzimidazoles and their use for inducing apoptosis |
| 04/19/2011 | CA2464000C 2-phenyl benzimidazoles and imidazo-[4,5]-pyridines as cdsi/chk2-inhibitors and adjuvants to chemotherapy or radiation therapy in the treatment of cancer |
| 04/19/2011 | CA2393802C 3-aminoquinazolin-2,4-dione antibacterial agents |
| 04/16/2011 | CA2777223A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011044229A1 2h-pyrrol-5-amine derivatives as alpha adrenergic receptor modulators |
| 04/14/2011 | WO2011044001A1 Compounds and compositions as modulators of gpr119 activity |
| 04/14/2011 | WO2011043568A2 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043479A1 Therapeutic agent for cerebral infarction |
| 04/14/2011 | WO2011042798A1 Pyrazoles derivatives modulators of calcium release -activated calcium channel and methods for treatment of non- small cell lung cancer |
| 04/14/2011 | WO2011042797A1 Pyrazole derivatives as modulators of calcium release -activated calcium channel |
| 04/14/2011 | WO2011042477A1 Substituted pyrroles and imidazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042475A1 Substituted pyrazoles as estrogen receptor ligands |
| 04/14/2011 | WO2011042389A2 Phenylpyri(mi)dinylazoles |
| 04/14/2011 | US20110086897 (E)-N-(2-Amino-phenyl)-3--acrylamide salts |
| 04/14/2011 | US20110086889 Tetrazole compounds as orexin receptor antagonists |
| 04/14/2011 | US20110086877 Small Molecule Inhibitors of Botulinum Neurotoxins |
| 04/14/2011 | US20110086860 Compound |
| 04/14/2011 | US20110086854 Novel n-substituted-pyrrolidines as inhibitors of mdm2-p-53 interactions |
| 04/14/2011 | US20110086834 Alkynyl alcohols as kinase inhibitors |
| 04/14/2011 | US20110086759 Chemical compounds |
| 04/14/2011 | US20110085974 Small molecule ligand-drug conjugates for targeted cancer therapy |
| 04/14/2011 | US20110084256 Condensed-cyclic compound and organic light emitting diode including organic layer containing the condensed-cyclic compound |
| 04/14/2011 | CA2784277A1 Pyrazoles derivatives modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer |
| 04/14/2011 | CA2776842A1 Pyrazole derivatives as modulators of calcium release-activated calcium channel |
| 04/14/2011 | CA2774573A1 Compounds and compositions as modulators of gpr119 activity |
| 04/14/2011 | CA2774133A1 Novel compounds effective as xanthine oxidase inhibitors, method for preparing the same, and pharmaceutical composition containing the same |
| 04/14/2011 | CA2773205A1 Phenylpyri(mi)dinylazoles |
| 04/13/2011 | EP2309564A1 Phosphorescent light-emitting composition and light-emitting element comprising the composition |
| 04/13/2011 | EP2308870A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308867A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses |
| 04/13/2011 | EP2308866A1 Phenylpyri(mi)dinylpyrazoles and their use as fungicides |
| 04/13/2011 | EP2308855A1 2,4-Diaminopyrimidine derivatives |
| 04/13/2011 | EP2308854A1 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 04/13/2011 | EP2308838A1 Nitrogen-containing aromatic heterocyclyl compound |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2307419A2 Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds |
| 04/13/2011 | EP2307404A2 Cosmetic composition, compound, and cosmetic treatment method |
| 04/13/2011 | EP2307403A2 Cosmetic composition, cosmetic treatment method and 4-oxo-1,4-dihydropyrimidin-2-yl compounds |
| 04/13/2011 | EP2307402A1 Imidazo-pyridine derivatives as activin-like receptor kinase (alk4 or alk5) inhibitors |
| 04/13/2011 | EP2307387A1 Novel heterocyclyl compounds for treatment of cardiovascular disease |
| 04/13/2011 | EP2307385A1 2 -arylaminoquinazolines for treating proliferative diseases |
| 04/13/2011 | EP2307363A1 Piperidyl acrylamide antogonists of ccr2 |
| 04/13/2011 | EP2307008A1 Substituted indolyl and indazolyl derivatives and uses thereof |
| 04/13/2011 | EP2306990A1 Pharmaceutical composition comprising n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2- dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1 h-pyrrole-3-carboxamide |
| 04/13/2011 | EP1585737B8 Uracils having a herbicidal activity |
| 04/13/2011 | EP1140085B1 Azabicycloalkanes as ccr5 modulators |
| 04/13/2011 | CN1882547B 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 04/13/2011 | CN1625400B 2,4-pyrimidinediamine compounds and their uses |
| 04/13/2011 | CN102015717A Chemokine receptor modulators |
| 04/13/2011 | CN102015694A Pyridazinone derivatives |
| 04/13/2011 | CN102015693A Compounds that are ERK inhibitors |
| 04/13/2011 | CN102015692A Heterocyclic derivatives as hepatitis c virus inhibitors |
| 04/13/2011 | CN102015691A Imidazo-pyridine derivatives as activin-like receptor kinase (ALK4 or ALK5) inhibitors |
| 04/13/2011 | CN102015690A Catalyzed carbonylation in the synthesis of angiotensin II antagonists |
| 04/13/2011 | CN102015686A Novel heterocyclic compounds and uses therof |
| 04/13/2011 | CN102015685A Substituted dihydropyrazolones as inhibitors of HIF-prolyl-4-hydroxylases |
| 04/13/2011 | CN102015680A New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors |
| 04/13/2011 | CN102015662A 3,5-diamino-6-chloro-pyrazine-2-carboxylic acid derivatives and their use as epithelial sodium channel blockers for the treatment of arway diseases |
| 04/13/2011 | CN102015661A Arylpyrazinone derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 04/13/2011 | CN102015660A 2-aminoquinazoline derivative |
| 04/13/2011 | CN102015659A Substituted pyridazinylmethyl sulfonamides |
| 04/13/2011 | CN102015657A 1,3 imidazolidine derivatives and their use in the production of carbapenem |
| 04/13/2011 | CN102015656A Phenylpropionic acid derivative and use thereof |
| 04/13/2011 | CN102015642A Novel 3-aminoalkyl-1,3-dihydro-2H-indol-2-one derivatives, preparation thereof and therapeutic use thereof |
| 04/13/2011 | CN102015640A Substituted 4-aminocyclohexane derivatives for the treatment of pain |
| 04/13/2011 | CN102015639A Compounds for use in stabilizing p53 mutants |